ArticleBreast cancer research and treatment2026
Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial.
Kamaria L Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.